General
Preferred name
PIROXICAM
Synonyms
CP-16171 ()
Piroxicam (Feldene) ()
PIROXICAM OLAMINE ()
CP 16171 ()
Piroflam 10 ()
Piroflam 20 ()
Feldene P ()
Pirozip 10 ()
Feldene 20 ()
Kentene ()
NSC-666076 ()
Flamatrol ()
Pirozip 20 ()
CP-16,171 ()
Feldene ()
Brexidol ()
Larapam ()
CP-16,171-85 ()
CP-16171-85 ()
CP-1617185 ()
Piroxicam-d3 ()
P&D ID
PD001795
CAS
36322-90-4
942047-64-5
Tags
drug candidate
natural product
drug
available
Approved by
FDA
First approval
1982
Drug Status
investigational
approved
Drug indication
Analgesic
Anti-Inflammatory,Anti-Inflammatory
Anti-Inflammatory
Pain
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Piroxicam is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic activity.
Drug formulations contain β-cyclodextrin to increase bioavailability eg piroxicam betadex has PubChem CID 54723875. (GtoPdb)
DESCRIPTION Cyclooxygenase (COX) inhibitor (LOPAC library)
DESCRIPTION Cyclooxygenase-1 (COX-1) inhibitor (Tocriscreen Total)
Cell lines
1
Organisms
3
Compound Sets
25
AdooQ Bioactive Compound Library
A10736
Cayman Chemical Bioactives
13368
33248
ChEMBL Approved Drugs
CHEMBL527
ChEMBL Drugs
CHEMBL527
CHEMBL2106953
Drug Repurposing Hub
DrugBank
DB00554
DrugBank Approved Drugs
DB00554
DrugCentral
2210
DrugCentral Approved Drugs
2210
DrugMAP
DMTK234
DrugMAP Approved Drugs
DMTK234
DrugMatrix
Guide to Pharmacology
7273
LOPAC library
LSP-MoA library (Laboratory of Systems Pharmacology)
CHEMBL527
MedChem Express Bioactive Compound Library
HY-B0253
NCATS Inxight Approved Drugs
13T4O6VMAM
NIH Clinical Collections (NCC)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
Piroxicam(Feldene)
TargetMol Bioactive Compound Library
T0758
The Spectrum Collection
Tocriscreen Total
External IDs
63
Properties
(calculated by RDKit )
Molecular Weight
331.06
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
2
Rotatable Bonds
2
Ring Count
3
Aromatic Ring Count
2
cLogP
1.58
TPSA
99.6
Fraction CSP3
0.07
Chiral centers
0.0
Largest ring
6.0
QED
0.87
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Selectivity
COX
Pathway
Immunology/Inflammation
Neuroscience
Indication
osteoarthritis, rheumatoid arthritis
Target
PTGS1, PTGS2
MOA
cyclooxygenase inhibitor
Therapeutic Class
Analgesics
Source data